Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Travere Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$7.4

2024-05-31

Market Capitalization

$564.9 M

2024-05-31

Revenue

$145.2 M

FY, 2023

CreditSafe Score

?
Score changed on Jun 12, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue28.2M99.9M133.6M154.9M164.2M175.3M198.3M227.5M212.0M145.2M
Revenue growth, %254.2%33.7%
Cost of goods sold571.0K2.2M4.6M3.6M5.5M5.2M6.1M6.8M7.6M11.5M
Gross profit27.6M97.7M129.0M151.3M158.7M170.1M192.2M204.4M133.8M
Gross profit margin, %98.0%97.8%96.6%97.7%96.6%97.0%96.9%96.4%92.1%
General and administrative expense1.3M17.7M59.6M79.5M92.8M101.3M103.7M129.0M135.8M149.9M220.2M265.5M
Operating expense total1.8M24.8M107.4M130.0M163.7M205.1M238.8M307.5M368.4M382.5M471.0M521.9M
EBIT(24.0M)(79.8M)(50.7M)(58.2M)(53.8M)(80.0M)(137.4M)(176.2M)(161.8M)(266.6M)(388.1M)
EBIT margin, %-283.0%-50.8%-43.6%-34.7%-48.7%-78.3%-88.8%-125.7%-267.2%
Interest income21.8K10.1M5.0M2.0M6.3M21.8M
Interest expense105.9K46.3K7.4M7.7M759.0K1.2M5.5M(20.1M)11.3M11.3M
Pre tax profit(33.7M)(113.4M)105.5M(57.6M)(58.4M)(101.9M)(146.4M)(188.8M)(179.7M)(278.2M)(376.1M)
Income tax expense(1.9K)(75.8K)2.5M11.8M9.7M1.4M811.0K(21.0K)(19.4M)409.0K313.0K223.0K
Net Income(30.3M)(33.8M)(110.9M)117.2M(47.9M)(59.7M)(102.7M)(146.4M)(169.4M)(180.1M)(278.5M)(111.4M)
EPS(4.4)(1.5)

Footer menu